BIVI

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

11/19 09:00 am

BioVie to Host Live Investor Webinar and Q&A on Oct. 8

09/26 08:00 am

BioVie Inc. Announces Pricing of $12 Million Public Offering

08/07 08:43 pm

BioVie Inc. Announces Pricing of $12 Million Public Offering

08/07 08:43 pm

BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology

07/24 08:00 am

Alzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight

07/08 01:00 pm

BIOVIE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioVie Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

04/30 09:00 pm

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

04/16 08:00 am

BioVie Inc. Announces Pricing of Public Offering

09/23 10:26 pm

BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID

09/03 08:00 am

BioVie Announces Clinical Data Showing Epigenetic Basis for How Bezisterim May Modulate Inflammation and the Biological Aging Process at the 11th Aging Research and Drug Discovery Meeting

08/27 08:45 am

BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson’s Disease at 2024 ATMRD Congress

06/20 08:00 am

Join BioVie’s Exclusive Live Investor Webinar and Q&A Session on June 26

06/12 08:24 am

BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID

04/29 08:00 am

BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation

04/18 08:00 am

Bears are Losing Control Over BioVie Inc. (BIVI), Here's Why It's a 'Buy' Now

03/12 09:55 am

BioVie Inc. Announces Closing of Public Offering

03/06 06:00 pm

Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher

03/04 03:34 pm

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

03/04 02:29 pm

Gold Gains 1%; JOANN Shares Plummet

03/04 01:05 pm

Dow Falls Over 100 Points; Sea Posts Upbeat Sales

03/04 10:44 am

Why BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving Premarket

03/04 09:04 am

BioVie Inc. Announces Pricing of Public Offering

03/04 02:32 am

Top Habits Penny Stocks Traders Need to Follow

03/02 07:18 am

BioVie Inc. Announces Proposed Public Offering of Common Stoc

03/01 05:58 pm

Crude Oil Rises Over 2%; Fisker Shares Plummet

03/01 03:32 pm

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

03/01 02:19 pm

Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February

03/01 01:16 pm

US Stocks Mixed; Dell Posts Upbeat Results

03/01 10:47 am

BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024

03/01 09:00 am

BioVie Inc. (BIVI) Loses -46.95% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

12/11 10:35 am

BioVie: Update Following Topline Results (Rating Downgrade)

12/02 01:44 am

The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie

12/01 06:09 am

Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More

11/30 11:33 am

BioVie (BIVI) Falls 61% Despite Upbeat Alzheimer's Study Data

11/30 11:20 am

Dow Jumps Over 100 Points; Hormel Foods Earnings Miss Estimates

11/29 03:20 pm

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

11/29 03:02 pm

Crude Oil Rises 1%; Rover Group Shares Spike Higher

11/29 01:05 pm

Nasdaq Surges Over 100 Points; US Economy Expands Faster Than Expected

11/29 10:48 am

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer’s Disease

11/29 09:00 am

Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket

11/16 09:08 am

Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

10/31 01:36 pm

BioVie to Host Conference Call and Webcast Wednesday November 1, 2023 at 8:00 AM ET

10/30 08:00 am

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

10/25 01:49 pm

Blinded Data Presented at CTAD Suggest that NE3107 is Biologically Active and May Have Impact on Cognitive, Biomarker, and Imaging Endpoints Among Mild to Moderate Alzheimer’s Disease Patients

10/25 12:30 pm

Why Microsoft Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

10/25 08:03 am

Best Momentum Stocks to Buy for October 19th

10/19 10:00 am

BioVie to Present Blinded Data on NE3107 in the Treatment of Mild to Moderate Alzheimer’s Disease at CTAD

10/19 07:30 am

New Strong Buy Stocks for October 19th

10/19 06:55 am

BioVie to Participate in the Cantor Fitzgerald Global Healthcare Conference

09/19 08:00 am